Summary & Overview
HCPCS G8758: Completion of IBD Quality Measures
HCPCS Level II code G8758 documents that all quality actions for the inflammatory bowel disease (IBD) measures group have been completed for a patient. As a categorical quality-reporting code, G8758 is used in claims and administrative records to indicate fulfillment of the set of process and outcome measures tied to IBD care. Nationally, such codes matter because they standardize reporting across payers and support quality measurement programs that inform value-based contracting and public accountability.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an explanation of the code’s clinical context and service setting, discussion of payer adoption patterns and coding implications (where available), and guidance on what types of benchmarks and policy updates typically relate to quality-specified HCPCS codes. The publication outlines how G8758 ties to outpatient gastroenterology workflows, common documentation triggers for reporting, and the kinds of performance and administrative data analysts use when tracking IBD measure completion rates. If specific payer policies or modifiers are not provided in the source data, those items are noted as unavailable.
Billing Code Overview
HCPCS Level II code G8758 indicates that all quality actions for the applicable measures in the inflammatory bowel disease (IBD) measures group have been performed for this patient. This reflects completion of required quality measures related to the management and follow-up of patients with IBD.
-
Service type: Quality reporting / performance measure documentation
-
Typical site of service: Outpatient specialty care settings (gastroenterology clinics) and other ambulatory care locations where IBD quality measures are assessed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a confirmed diagnosis of inflammatory bowel disease who presents for routine outpatient disease-management follow-up. The patient has had prior visits, laboratory monitoring, medication reconciliation (including biologic therapy), vaccination status review, and documentation of disease activity and safety monitoring. During the visit the clinician confirms performance of all required quality actions for the applicable IBD measures group: medication reconciliation, assessment of disease activity and remission status, documentation of steroid-sparing strategies, appropriate laboratory monitoring (e.g., CRP, fecal calprotectin when indicated), vaccination counseling and administration status, screening for tuberculosis and hepatitis B prior to biologic initiation, and shared decision-making documentation. The clinical workflow includes pre-visit chart review by a nurse or medical assistant to collect recent labs and medication lists, point-of-care or lab testing as needed, clinician visit with focused IBD assessment and plan, and documentation in the electronic health record that all IBD quality measures were completed for the reporting period. The service represented by G8758 is a quality reporting action indicating that all measure elements for the IBD measures group were performed for this patient during the reporting interval.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service |